Your search returned 7 results

{0} results
{0} result

Blog Post

FDA shows that it means business in stopping stem cell clinics that put patients at risk

On Wednesday, FDA announced that it filed two complaints in federal court seeking injunctions to stop marketing efforts of unapproved stem cell treatments by US Stem Cell Clinic...

Blog Post

FDA issues new guidance documents on regenerative medicine but delays enforcement

Yesterday, the U.S. Food and Drug Administration (FDA) announced a comprehensive framework for development and oversight of regenerative medicine products, including innovative...

No results found for the matching keyword.

Loading data